Related Experiment Video
Updated: Jun 3, 2026
11:28
Isolating Lymphocytes from the Mouse Small Intestinal Immune System
Published on: February 28, 2018
Use of lectins as mitogens for lymphocytes
1Department of Transfusion Medicine, Edinburgh and S. E. Scotland Blood Transfusion Service, Edinburgh, Scotland.
Methods in Molecular Medicine
|March 5, 2011
Summary
Lectins are convenient mitogens that activate resting lymphocytes, including T-lymphocytes and B-lymphocytes, to proliferate and differentiate. These agents can induce cytokine synthesis and cytotoxic or suppressor functions, with some also showing in vivo mitogenicity.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Resting lymphocytes can be stimulated to proliferate by various agents.
- Lectins are a widely used and convenient class of mitogens for lymphocyte activation.
- Lymphocyte activation is crucial for immune responses and cellular differentiation.
Purpose of the Study:
- To review the role of lectins as generic mitogens for lymphocyte activation.
- To describe the differentiation pathways of T-lymphocytes and B-lymphocytes induced by lectins.
- To highlight the in vitro and in vivo effects of lectin-induced lymphocyte proliferation.
Main Methods:
- Literature review on lectin-mediated lymphocyte activation.
- Analysis of T-lymphocyte and B-lymphocyte responses to mitogenic lectins.
- Examination of cellular differentiation markers (CD4, CD8) and functions (cytokine synthesis, suppression, cytotoxicity).
Main Results:
- Strongly mitogenic lectins activate a high proportion of T-lymphocytes, leading to helper (CD4+) or suppressor/cytotoxic (CD8+) cell differentiation.
- Some resting B-lymphocytes also undergo activation, proliferation, and differentiation into plasma cells.
- Evidence suggests that some lectins exhibit mitogenic activity in vivo, not just in vitro.
Conclusions:
- Lectins are effective and versatile reagents for inducing lymphocyte proliferation and differentiation.
- Lectin stimulation provides a model for studying T-cell and B-cell activation pathways.
- The in vivo effects of lectins warrant further investigation for potential therapeutic applications.
